[
  {
    "ts": null,
    "headline": "Elevance Health Inc. stock underperforms Wednesday when compared to competitors despite daily gains",
    "summary": "Elevance Health Inc. stock underperforms Wednesday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=99617c59aaa86b6dd62165fc0c3c17e38541640a95bf92f8cf29fe42b424b426",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753893900,
      "headline": "Elevance Health Inc. stock underperforms Wednesday when compared to competitors despite daily gains",
      "id": 136172639,
      "image": "",
      "related": "ELV",
      "source": "MarketWatch",
      "summary": "Elevance Health Inc. stock underperforms Wednesday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=99617c59aaa86b6dd62165fc0c3c17e38541640a95bf92f8cf29fe42b424b426"
    }
  },
  {
    "ts": null,
    "headline": "Cigna to Report Q2 Earnings: Can Evernorth Offset Healthcare Weakness?",
    "summary": "CI's Q2 results are likely to hinge on Evernorth's growth as core healthcare revenues and premiums face steep declines.",
    "url": "https://finnhub.io/api/news?id=12413cac5ee510eaeab78b4e3a24cbeb6f2c8b136ae18da0622dfcc14908688b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753889460,
      "headline": "Cigna to Report Q2 Earnings: Can Evernorth Offset Healthcare Weakness?",
      "id": 136149301,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "CI's Q2 results are likely to hinge on Evernorth's growth as core healthcare revenues and premiums face steep declines.",
      "url": "https://finnhub.io/api/news?id=12413cac5ee510eaeab78b4e3a24cbeb6f2c8b136ae18da0622dfcc14908688b"
    }
  },
  {
    "ts": null,
    "headline": "Elevance names former Cencora CEO to board",
    "summary": "Steve Collis’ three decades of experience at a major drug distributor could prove helpful for Elevance as it continues to build out its pharmacy services.",
    "url": "https://finnhub.io/api/news?id=e77cb9378aeb48b121d20f2b960a92fc24fa3eee20d6d5773241d58a60b38bf8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753866780,
      "headline": "Elevance names former Cencora CEO to board",
      "id": 136130306,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "Steve Collis’ three decades of experience at a major drug distributor could prove helpful for Elevance as it continues to build out its pharmacy services.",
      "url": "https://finnhub.io/api/news?id=e77cb9378aeb48b121d20f2b960a92fc24fa3eee20d6d5773241d58a60b38bf8"
    }
  }
]